Jung Hui Chung
Financieel Directeur/CFO bij UNITED BIOPHARMA INC
Profiel
Jung Hui Chung is currently an Independent Director at Shian Yih Electronic Industry Co. Ltd.
and Head-Finance, Head-Accounting & Deputy Spokesman at United BioPharma, Inc. He was previously an Independent Director at Fitipower Integrated Technology, Inc. and Head-Financial & Accounting Department at Solid State System Co., Ltd.
Chung is a graduate of The University of Reading and National Chengchi University.
Actieve functies van Jung Hui Chung
| Bedrijven | Functie | Begin |
|---|---|---|
| SHIAN YIH ELECTRONIC INDUSTRY CO.,LTD | Directeur/Bestuurslid | 01-06-2007 |
| UNITED BIOPHARMA INC | Financieel Directeur/CFO | - |
Eerdere bekende functies van Jung Hui Chung
| Bedrijven | Functie | Einde |
|---|---|---|
| FITIPOWER INTEGRATED TECHNOLOGY INC. | Directeur/Bestuurslid | - |
| SOLID STATE SYSTEM CO., LTD. | Financieel Directeur/CFO | - |
Opleiding van Jung Hui Chung
| The University of Reading | Graduate Degree |
| National Chengchi University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SOLID STATE SYSTEM CO., LTD. | Electronic Technology |
| SHIAN YIH ELECTRONIC INDUSTRY CO.,LTD | Electronic Technology |
| FITIPOWER INTEGRATED TECHNOLOGY INC. | Electronic Technology |
| Bedrijven in privébezit | 1 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
